Search

Your search keyword '"Wiedemann, Aurelie"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Wiedemann, Aurelie" Remove constraint Author: "Wiedemann, Aurelie"
28 results on '"Wiedemann, Aurelie"'

Search Results

1. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

2. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

3. Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohort

4. Association of Country Income Level With the Characteristics and Outcomes of Critically Ill Patients Hospitalized With Acute Kidney Injury and COVID-19

5. Thrombotic and hemorrhagic complications of COVID-19 in adults hospitalized in high-income countries compared with those in adults hospitalized in low- and middle-income countries in an international registry

6. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

7. CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death

9. Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques

11. Complement-dependent mpox virus-neutralizing antibodies in infected and vaccinated individuals

13. CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death

14. Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection

15. Author response: Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection

18. COVID-19 symptoms at hospital admission vary with age and sex

19. SARS-CoV-2 mechanistic correlates of protection: insight from modelling response to vaccines

20. Modelling the response to vaccine in nonhuman primates to define SARS-CoV-2 mechanistic correlates of protection.

21. HGF and CXCL13, Two Antagonizing Cytokines in Lung Inflammation and Fibrosis, Predict the Severity and the Mortality of COVID-19

22. Safety and immunogenicity of a two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Europe (EBOVAC2): a randomised, observer-blind, participant-blind, placebo-controlled, phase 2 trial

23. T-cell and Transcriptomic Responses to Prime-boost Strategies of 3 HIV Vaccines(MVA HIV-B; LIPO-5; GTU-MultiHIV B)-ANRS/INSERM VRI01 Trial

24. The value of open-source clinical science in pandemic response: lessons from ISARIC

25. Detection of SARS-CoV-2 N-antigen in blood during acute COVID-19 provides a sensitive new marker and new testing alternatives

26. HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates

28. Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countries

Catalog

Books, media, physical & digital resources